Wound Management Formulary

The wound management formulary has been developed by the Joint Wound Management Formulary Group. Please use the links below to navigate to the relevant sections.

Wound Management Formulary – full text – updated contact details March 2018

Contacts

 

*Patients should be encouraged to self-care where appropriate. Practitioners’ responsibilities include a self-care risk assessment, providing patient information leaflets and advising about red flags and when these need to be escalated, and how*.

 

Contributors

 

Wound Care Bulletins

Bulletin Two – Barrier Film Products

Bulletin Three – Maggots

Bulletin Four – Comfifast

Bulletin Five – Top Tips 1

Bulletin Six – Quantities

Quick Reference Guides

Quick reference guide Debrisoft FINAL

 

Public Health England (PHE)

PHE notes in it’s guidance on primary care infections that widespread use of topical antibiotics, especially those agents also available systemically, is to be avoided. If use is indicated topical use should be limited in most cases.

 

Paraffin-containing skin preparations (emollients)

BBC News Health has recently highlighted the dangers of using paraffin-containing skin preparations whilst smoking or using naked flames. For further information see this document and leaflet which include advice for both healthcare professionals and patients.

 

Advice on diamorphine and intrasite gel

The CDAO are aware of the unlicensed use of Intrasite gel and Diamorphine Injection in certain settings.

The decision to use this would be a clinical judgement for the individual prescriber.

In all cases, if this is the chosen treatment, both the person administering the treatment, and the patient, must be  aware of its unlicensed status. There must also be a full audit trail for the use of the Diamorphine (including destruction details of any part ampoules that may have been discarded)

Regarding treatment suitability and evidence please contact the Yorkshire Cancer Network

 

Resources

Wound dressing selection chart

CHFT – Post-operative wound site information and advice

 

 

 

 

Formulary produced by: Joint Wound Management Formulary Group
Original date: March 2008
First review: March 2010
Second review: April 2012
Third review: July 2015

Fourth review: May 2016
Originally approved by SWY Area Prescribing Committee: 28 March 2008.